Quick Answer
Regenerative Medical Technology Group Inc. reported Earnings Per Share Diluted of $0.44 (loss) per share for the year ending 2024.
- Regenerative Medical Technology Group Inc. showed an increase of +44.3% in Earnings Per Share Diluted from 2023 to 2024.
- This data is from Regenerative Medical Technology Group Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2021 to 2024), Regenerative Medical Technology Group Inc.'s Earnings Per Share Diluted has grown by 60.7%.
- Historical annual values: Fiscal year 2024: $0.44 (loss) per share | Fiscal year 2023: $0.79 (loss) per share | Fiscal year 2022: $0.45 (loss) per share | Fiscal year 2021: $1.12 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: